SCD and breast carcinoma: Thus, to assess the possible contribution of SCD1 to breast cancer cell migration, both siRNA-mediated inactivation and pharmacological inhibition of the enzyme were performed in MCF-7 and MDA-MB-231 cells and their migratory activity was evaluated by wound-healing assay.